Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Accumulated Expenses: 2024

Historic Accumulated Expenses for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to $11.4 million.

  • Pyxis Oncology's Accumulated Expenses fell 43.12% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 43.12%. This contributed to the annual value of $11.4 million for FY2024, which is N/A change from last year.
  • Per Pyxis Oncology's latest filing, its Accumulated Expenses stood at $11.4 million for FY2024.
  • In the past 5 years, Pyxis Oncology's Accumulated Expenses ranged from a high of $11.4 million in FY2024 and a low of $11.4 million during FY2024.
  • Moreover, its 1-year median value for Accumulated Expenses was $11.4 million (2024), whereas its average is $11.4 million.